Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “paclitaxel”

5 pharma patents match "paclitaxel" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "paclitaxel" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “paclitaxel” · 30,257 patents in full index Clear search

  1. US 11944617

    Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4

    Corcept Therapeutics Incorporated · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  2. US 11285145

    Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4

    Corcept Therapeutics Incorporated · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  3. US 8426385

    Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof

    Hainan Hdeton Science and Technology Co., Ltd. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  4. US 7179588

    Assay for the detection of paclitaxel resistant cells in human tumors

    The Board of Regents of the University of Texas System · Granted Feb 20, 2007 · Expires Feb 15, 2027

    granted
  5. US 6569459

    Method of administration of paclitaxel-plasma protein formulation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 27, 2003 · Expires May 22, 2023

    expired